拉米夫定联合α-2b干扰素治疗慢性乙型肝炎疗效观察
出处
《浙江医学》
CAS
2005年第2期150-151,共2页
Zhejiang Medical Journal
参考文献6
-
1中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量：14012
-
2舒丹,杨大国,高志良,马为民,戴炜,王松,乐晓华.干扰素α联合拉米夫定治疗慢性乙型肝炎的短期疗效及其影响因素[J].中华传染病杂志,2003,21(2):118-121. 被引量：16
-
3Korba BE. In Vitro evaluation of combination therapies against hepatitis B viral replication. Antiviral Res, 1996, 29: 49.
-
4Mutimen D, Naoumov N, Honkop P, et al. Combination alphinterfern and Lamivudime therapy for alpha-interfen-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol, 1998, 28: 923.
-
5Schalm SW, Healthcote J, Cianciara J, et al. Lamivudine and alpha interfern combination treatment of patients with chronic hepatitis B infection: a randomised trial. Gut, 2000, 46: 562.
-
6Marinos G, Naoumov NV, Williams R. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection. Hepatology, 1996, 24:991.
二级参考文献8
-
1病毒性肝炎防治方案（试行）[J].中华传染病杂志,1995,13(4):241-247. 被引量：1767
-
2Korba BE. In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res, 1996, 29: 49-64.
-
3Schalm SW, Heathcote J, Cianclara J, et al. Lamivudlne and alpha interferon combination treatment of patients with chronichepatitis B infection: a randomised trial. Gut, 2000, 46: 562-568.
-
4Schiff E, Karayalcin S, Grimm I, et al. A placebo-controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy.Hepatology, 1998, 28:388a.
-
5Mutimer D, Naoumov N, Honkoop P, et al. Combination alphainterferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol,1998,28:923-929.
-
6Marinos G, Naoumov NV, Williams R. Impact of complete inhibition of viral replication on the cellular immune response inchronic hepatitis B virus infection. Hepatology, 1996, 24:991-995.
-
7Leung NWY, Lai CL, Chang TT, et al. Three year lamivudene therapy in chronic HB.J Hepatol, 1999,30 Suppl, 1:59.
-
8Cotonat T, Quiroga JA, Lopez-Alcorocho JM, et al. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody positive patients.Hepatology, 2000, 31:502-506.
共引文献14021
-
1刘洋.复方木鸡颗粒联合替诺福韦治疗代偿期乙型肝炎肝硬化患者的临床研究[J].慢性病学杂志,2019,0(12):1853-1854.
-
2李钊,黄宛香,李繁.乙型肝炎病毒感染肝硬化AST/ALT和LSM值与Child-Pugh分级及临床分期关系[J].热带医学杂志,2023,23(11):1593-1596. 被引量：1
-
3曾远松,黄柳春.茵郁芪灵汤联合恩替卡韦治疗慢性乙型肝炎的疗效观察[J].内蒙古中医药,2021,40(5):13-14. 被引量：2
-
4宫笑一,刘守华.代偿期乙肝肝硬化患者服用恩替卡韦对血清甲状腺激素水平的影响[J].中国农村卫生,2018,0(16):78-78.
-
5王雪艳,张旭东.甘草酸二铵对乙肝肝硬化患者TBIL、CⅣ及炎性因子的影响分析[J].医药论坛杂志,2021,42(16):7-10.
-
6欧阳福生.老年病毒性肝炎267例临床报告[J].山东大学学报（医学版）,2014,52(S01):83-84.
-
7潘晓华.阿德福韦酯联合拉米夫定治疗乙肝肝硬化患者80例8年的临床报道[J].世界最新医学信息文摘,2020(48):108-109.
-
8付振双.恩替卡韦治疗失代偿期慢性乙型病毒性肝炎肝硬化的临床研究[J].世界最新医学信息文摘,2020(2):150-150. 被引量：1
-
9陈新梅,陈昆迪.重型肝病转归与季节关系的探讨[J].医学信息,2018,31(A02):62-63.
-
10王同兴,于卫叶.联合检测血清PCⅢ,HA,LN对肝纤维化的诊断价值[J].医学信息（医学与计算机应用）,2016,29(28):217-218. 被引量：2
-
1把爱萍,戎敏之.α-2b干扰素腹腔灌注治疗恶性腹水的观察与护理[J].中华医学全科杂志,2003,2(5):82-83.
-
2宋利琼,张昌菊.莪术油联合干扰素对小鼠宫颈癌端粒酶活性和细胞凋亡的影响[J].上海中医药杂志,2006,40(7):68-69. 被引量：29
-
3杨根领,甄中峰,梁玉国.α-2b干扰素联合苦参素治疗慢性乙型肝炎疗效观察[J].山东医药,2003,43(32):57-57. 被引量：1
-
4李凯,马育林,宋金钢,姚智,杨海贤,李秀英.α－2b干扰素瘤内注射治疗41例骨软组织肿瘤及转移癌[J].中国肿瘤临床,1996,23(12):864-869. 被引量：2
-
5李凯,马育林,杨蕴,张瑾.干扰能瘤内注射治疗实体瘤疗效观察(附13例报告)[J].中国肿瘤生物治疗杂志,1995,2(4):277-278.
-
6刘欣,孙自敏.α-2b干扰素联合低剂量阿糖胞苷治疗慢性粒细胞白血病[J].国外医学（遗传学分册）,2000,23(5):253-255.
-
7张建国,史海军,程远合,马建新,鲁功成.α-2b干扰素加顺铂预防膀胱癌术后复发的远期疗效[J].实用肿瘤学杂志,2004,18(2):97-100. 被引量：1
-
8翟云芝.α-2b干扰素治疗癌性胸水50例疗效观察[J].工企医刊,2000,13(3):10-11.
-
9刘尚莹,曹晓明,武学清,胡佩胜.α-2b干扰素膀胱灌注预防表浅性膀胱肿瘤术后复发[J].中华肿瘤杂志,2000,22(6):522-522. 被引量：6
-
10姜振宇,王静,王春艳,王冠军,白瑛.α-2b干扰素联合VAD方案治疗老年人多发性骨髓瘤25例[J].中国老年学杂志,2001,21(6):461-461. 被引量：2
